Challenge

A leading immuno-oncology biotech company with a pipeline of novel, first-in-class clinical stage assets needed medical support for multiple clinical and medical affairs activities in Europe and the United States.

Solution

Our support included providing advice and assistance with the following:

• clinical strategy and execution of the clinical development plans for the company’s drug candidates
• drug safety and pharmacovigilance
• fostering existing and future relationships with key opinion leaders, medical advisors and medical advisory boards.

We also assessed portfolio expansion opportunities and other corporate development activities from a clinical development and medical perspective.

View Additional Immunotherapy Case Studies